<?xml version="1.0" encoding="UTF-8"?>
<p>Pneumonia is an extremely common manifestation of these three viral diseases. It typically follows the initial presentation of a flu-like illness including fever, myalgia, cough and malaise, occurring in SARS (Sampathkumar 
 <italic>et al</italic>. 
 <xref rid="bib53" ref-type="bibr">2003</xref>), MERS (Banik, Khandaker and Rashid 
 <xref rid="bib6" ref-type="bibr">2015</xref>) and COVID-19 (Jiang 
 <italic>et al</italic>. 
 <xref rid="bib26" ref-type="bibr">2020</xref>). In fact, up to 70% (Banik, Khandaker and Rashid 
 <xref rid="bib6" ref-type="bibr">2015</xref>) or even 90% (Saad 
 <italic>et al</italic>. 
 <xref rid="bib52" ref-type="bibr">2014</xref>) of MERS patients eventually develop pneumonia, and all COVID-19 hospitalized patients in an early cohort from Wuhan developed pneumonia (Huang 
 <italic>et al</italic>. 
 <xref rid="bib22" ref-type="bibr">2020</xref>). In COVID-19, this pneumonia appears to predict poor outcome; 25.9% (72/278) of patients in a pooled cohort with pneumonia were admitted to an intensive care unit (ICU) (Lai 
 <italic>et al</italic>. 
 <xref rid="bib30" ref-type="bibr">2020</xref>).
</p>
